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Abstract
Background: Common warts (verruca vulgaris) are benign epithelial proliferations associated with human
papillomavirus (HPV) infection. Salicylic acid and cryotherapy are the most frequent treatments for common warts,
but can be painful and cause scarring, and have high failure and recrudescence rates. Topical vitamin A has been
shown to be a successful treatment of common warts in prior informal studies.
Case: The subject is a healthy, physically-active 30 old female with a 9 year history of common warts on the back
of the right hand. The warts resisted treatment with salicylic acid, apple cider vinegar and an over-the-counter
blend of essential oils marketed for the treatment of warts. Daily topical application of natural vitamin A derived
from fish liver oil (25,000 IU) led to replacement of all the warts with normal skin. Most of the smaller warts had
been replaced by 70 days. A large wart on the middle knuckle required 6 months of vitamin A treatment to
resolve completely.
Conclusion: Retinoids should be further investigated in controlled studies to determine their effectiveness in
treating common warts and the broad range of other benign and cancerous lesions induced by HPVs.
Background
Human papillomaviruses (HPVs) are the causative agents
of a variety of benign and cancerous lesions of the skin
and other epithelial surfaces. At least 189 HPV genotypes
have been described [1]. Most HPV types are associated
with one or a few histopathologically distinct types of
lesions and may be restricted to a particular location on
the body. HPV types 2, 4, 26, 29 and others are responsible
for common warts (verruca vulgaris), which are slightly
raised rough surface epithelial proliferations that occur
most often on the hands, but can also grow elsewhere on
the body. Other types of warts include plantars warts (ver-
ruca plantaris) that occur most commonly on the soles of
the feet (HPV 1 and others) [2], flat warts (verruca plana)
usually appearing on the face (HPV 3, 10, 38 and others)
[3], butcher’s warts of the hands and fingers (HPV 7) [4],
and oral, gentialoranogenital warts (condyloma acuminata;
HPV 6, 11, 16, 18 and many others) [5]. While common
warts can affect patients’ quality of life by causing adverse
psychological effects or negative social perception, certain
types of HPV may induce life-threatening malignancies.
HPV is associated with virtually 100% of cervical cancers,
and a high portion of cancers of the penis and anus [5-7].
HPV 16 has also been strongly associated with various
head and neck cancers, including head and neck squa-
mous cell carcinoma and oropharyngeal carcinoma of the
tonsils [8-10]. The incidence of HPV-induced oral cancers
appears to be increasing [11].
Many different treatments have been described for
HPV-induced lesions. Salicylic acid (SCA) and cryother-
apy, which are intended to kill HPV-infected cells, are the
most frequently employed treatments for common warts
by dermatologists. Over-the-counter (OTC) versions of
these treatments are also available. Numerous studies,
albeit with highly variable protocols, have examined the
efficacy of SCA and cryotherapy for treating HPV-induced
lesions (reviewed in [12]). The efficacy of these treatments
is low, and there is a high rate of recrudescence and
adverse effects (such as scarring). Although well-controlled
clinical trials have not been performed, retinoids are pro-
mising alternative treatments for warts [13-17]. Topical
vitamin A was an effective treatment of common warts in
a prior informal study [18]. Here, we present a well-
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documented case of topical vitamin A treatment of recalci-
trant common warts.
Case presentation
The subject is a healthy 30 year old woman of European
descent with an uneventful medical history. There was a
large (approximately 9 mm in diameter; large arrow
Figure 1A) common wart on the middle knuckle of the
right hand as well as 23 smaller warts (1 mm to 4 mm)
at the base of and behind the knuckle of the index fin-
ger (small arrows, Figure 1A). The large wart was first
noticed 9 years earlier. Within 1-2 years it had reached
its maximum size as well as spread to multiple sur-
rounding sites. Because of her occupation as a piano
teacher, the subject reported experiencing considerable
psychological distress over the visibility of the warts and
the need to frequently use her hands in front of others.
Over the course of the previous 2 years, several
treatments for common warts on the right hand were
unsuccessful despite perfect compliance. The treatments
attempted included two courses of essential oil blends
which were applied to all warts three times daily as direc-
ted. The initial preparation was marketed OTC for wart
treatment, guaranteed by the manufacturer to be effective
within 8 weeks, and consisted of cedrus, lycea, malaleuca
alternafolia, and limonium. After 3 months of perfect
application resulted in no change, a second specially-
formulated stronger blend was applied three times daily
for an additional 2 months. This consisted of a stronger
concentration of the same aforementioned essential oils
plus juniper and cypress. It resulted in no change. The
second unsuccessful treatment was an OTC 40% salicylic
acid preparation that was applied only to the large wart
for 3 months of daily application. The salicylic acid treat-
ment resulted in very little benefit and a plateau effect




16 weeks 6 months
Figure 1 Progressive clearance of verrucae vulgaris following daily topical application of vitamin A. Appearance of warts prior to vitamin
A treatment (Panel A) and at 70 days (Panel B), 16 weeks (Panel C) and 6 months (Panel D). Large arrow indicates large wart on knuckle
requiring the longest time to resolve. Small arrows indicate smaller warts cleared by 16 weeks.
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unsuccessful treatment was apple cider vinegar applied to
two of the smaller warts. The supradermal portion of the
warts sluffed off after a few days of apple cider vinegar
treatment, but promptly regrew. In addition, this treat-
ment resulted in moderate to severe irritation of the sur-
rounding skin.
Throughout the course of the failed attempts at treat-
ment, the number of warts increased. All warts had
returned to their original appearance prior to treatment
with vitamin A. The source of vitamin A was natural fish
liver oil (NOW® Foods, 25,000 IU softgels, Manufacturer
SKU: 733739003409). A needle was used to puncture the
softgels and the oil was applied topically to the warts every
night prior to sleep. The oil was allowed to soak into the
tissue before the excess oil was removed with a dry towel.
Soap was not used to wash the hands until the morning.
On 3-4 days of the week, the oil was applied a second
time, usually around midday. The daily topical application
of vitamin A led to replacement of all the warts with nor-
mal skin. Most of the smaller warts had been replaced
with normal skin by 70 days (Figure 1B). The largest wart
on the middle knuckle of the right hand, although
replaced by mostly normal tissue after 4 months of treat-
ment (Figure 1C), required 6 months of vitamin A treat-
ment to completely resolve (Figure 1D). The slight
discoloration of the tissue likely represents residual scar
tissue from prior unsuccessful treatments. Interestingly,
during the course of treatment three tiny warts on the left
hand also disappeared even though vitamin A was not
applied to them.
Conclusions
The case reported here is similar to experiences in prior
informal studies suggesting that topical vitamin A is an
effective treatment for verruca vulgaris. Topical vitamin A
should be further investigated as an alternative to the
most frequently-utilized wart treatments, cryotherapy and
SCA, which have relatively low cure rates [19-21]. In con-
trast to destructive or dermonecrotic treatments, topical
vitamin A treatment for warts is not painful and does not
lead to scarring. On the other hand, the treatment may
require several months for complete resolution of the
lesions, which can affect compliance. As in the current
case, warts with scar tissue as a result of prior tissue
destroying treatments, such as SCA, may require longer
vitamin A treatment. The location and size of the wart
may also affect time to resolution. Large plantar warts on
the feet typically take several months to resolve with topi-
cal vitamin A. Treatments such as SCA and cryotherapy
have a high rate of recrudescence that is not seen with
topical vitamin A treatment. Destructive treatments that
do not affect HPV replication must eliminate all virus
from the deep tissue, or commonly the wart will reestab-
lish quickly.
There are a number of plausible mechanisms by which
retinoids may affect HPV-induced lesions. Warts display
abnormal keratin expression [22-24]. Retinoids, such as
vitamin A, regulate epithelial cell differentiation and keratin
expression [25]. HPV cannot complete its replication cycle
in cultured cells suggesting that differentiation of epithelia
cells in tissues is important for HPV production [26]. HPV
replication appears to be synchronized with epithelial cell
differentiation [27,28]. Vitamin A may disrupt the interplay
of HPV replication and epithelial cell differentiation,
thereby allowing normal tissue to replace the warts. Pre-
vious studies have suggested that retinoids may also affect
HPV transcription or replication [29,30]. Furthermore,
HPV infection may alter retinoid signaling [31,32]. Immune
mechanisms may also be involved in wart clearance [33].
Vitamin A treatment may increase or prolong expression of
HPV T or B cell antigens allowing clearance of the warts by
immune mechanisms. The observation that three small
warts on the left hand of the current subject resolved simul-
taneously even though vitamin A was not applied directly
to them, suggests the possibility that vitamin A may evoke
or potentiate immune responses to warts. While it is unli-
kely that topical application could increase the systemic
levels of vitamin A substantially (hypervitaminosis A), a
modest systemic elevation of vitamin A levels by the topical
treatment may have affected the small warts on the left
hand.
Furthermore, warts can have psychologically devastating
effects on patients’ lives [34] and the emotional impact of
any treatment should not be overlooked. Treatment with
SCA, for example, requires carefully coating the wart with
a highly noticeable white film and may not be viable for
sufferers who are already self-conscious or whose warts
are on their face. In contrast, vitamin A oil is colourless,
easy to apply, and quickly absorbed into the tissues. In
addition, it does not irritate surrounding skin or lead to
drying or flaking. Because vitamin A causes the wart to
slowly dissolve and disappear, it represents an inconspicu-
ous treatment that does not attract further attention to the
wart and is unlikely to cause additional psychological
distress.
Because warts may “spontaneously” resolve, it is possible
that clearance of the warts after treatment with vitamin A
in this case was due to chance timing. However, this is
unlikely given that the warts had only increased in size
and number over the preceding 9 years. In addition, the
case is typical of subjects in a prior informal series in
which warts always began to clear within a few weeks of
initiating topical vitamin A treatment [18]. Tretinoin
(Retin A) and other retinoids besides vitamin A have been
successfully used in limited studies for the treatment of
warts [13-17]. The current case adds to the literature sug-
gesting that retinoids should be further investigated in
controlled studies to determine their effectiveness in
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treating common warts and the broad range of other
benign and cancerous lesions induced by HPVs.
Consent
Informed consent was obtained from the subject for
publication of this Case Report and accompanying
images.
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